239 related articles for article (PubMed ID: 19009535)
21. [Prenatal risk calculation: comparison between Fast Screen pre I plus software and ViewPoint software. Evaluation of the risk calculation algorithms].
Morin JF; Botton E; Jacquemard F; Richard-Gireme A
Ann Biol Clin (Paris); 2013; 71(1):31-8. PubMed ID: 23396428
[TBL] [Abstract][Full Text] [Related]
22. Follow up and evaluation of the Victorian first-trimester combined screening programme for Down syndrome and trisomy 18.
Jaques AM; Halliday JL; Francis I; Bonacquisto L; Forbes R; Cronin A; Sheffield LJ
BJOG; 2007 Jul; 114(7):812-8. PubMed ID: 17501960
[TBL] [Abstract][Full Text] [Related]
23. Current methods of prenatal screening for Down syndrome and other fetal abnormalities.
Saller DN; Canick JA
Clin Obstet Gynecol; 2008 Mar; 51(1):24-36. PubMed ID: 18303497
[TBL] [Abstract][Full Text] [Related]
24. Stepwise sequential screening for fetal aneuploidy.
Benn PA; Campbell WA; Zelop CM; Ingardia C; Egan JF
Am J Obstet Gynecol; 2007 Sep; 197(3):312.e1-5. PubMed ID: 17826434
[TBL] [Abstract][Full Text] [Related]
25. The impact of bias in MoM values on patient risk and screening performance for Down syndrome.
Nix B; Wright D; Baker A
Prenat Diagn; 2007 Sep; 27(9):840-5. PubMed ID: 17600858
[TBL] [Abstract][Full Text] [Related]
26. [Prenatal diagnostics in Arhus and Viborg Counties after implementation of first trimester risk assessment].
Tørring N; Jølving LR; Petersen OB; Holmskov A; Hertz JM; Uldbjerg N
Ugeskr Laeger; 2008 Jan; 170(1):50-4. PubMed ID: 18208717
[TBL] [Abstract][Full Text] [Related]
27. Screening options for Down syndrome: how women choose in real clinical setting.
Lo TK; Lai FK; Leung WC; Lau WL; Ng LS; Wong WC; Tam SS; Yee YC; Choi H; Lam HS; Sham AS; Tang LC; Chin RK
Prenat Diagn; 2009 Sep; 29(9):852-6. PubMed ID: 19441088
[TBL] [Abstract][Full Text] [Related]
28. Aneuploidy screening: what test should I use?
Berkowitz RL; Cuckle HS; Wapner R; D'Alton ME
Obstet Gynecol; 2006 Mar; 107(3):715-8. PubMed ID: 16507946
[TBL] [Abstract][Full Text] [Related]
29. Use of the combined first-trimester screen result and low PAPP-A to predict risk of adverse fetal outcomes.
Barrett SL; Bower C; Hadlow NC
Prenat Diagn; 2008 Jan; 28(1):28-35. PubMed ID: 18186146
[TBL] [Abstract][Full Text] [Related]
30. Trends in state/population-based Down syndrome screening and invasive prenatal testing with the introduction of first-trimester combined Down syndrome screening, South Australia, 1995-2005.
Muller PR; Cocciolone R; Haan EA; Wilkinson C; Scott H; Sage L; Bird R; Hutchinson R; Chan A
Am J Obstet Gynecol; 2007 Apr; 196(4):315.e1-7; discussion 285-6. PubMed ID: 17403402
[TBL] [Abstract][Full Text] [Related]
31. Experience on triple markers serum screening for Down's syndrome fetus in Hat Yai, Regional Hospital.
Lamlertkittikul S; Chandeying V
J Med Assoc Thai; 2007 Oct; 90(10):1970-6. PubMed ID: 18041410
[TBL] [Abstract][Full Text] [Related]
32. Age-independent first trimester screening for Down syndrome: analysis of three modified software programs with 6,508 pregnancies.
Hörmansdörfer C; Golatta M; Scharf A; Hillemanns P; Schmidt P
Arch Gynecol Obstet; 2011 Apr; 283(4):749-54. PubMed ID: 20364345
[TBL] [Abstract][Full Text] [Related]
33. Women's and health professionals' preferences for prenatal testing for Down syndrome in Australia.
Lewis SM; Cullinane FM; Carlin JB; Halliday JL
Aust N Z J Obstet Gynaecol; 2006 Jun; 46(3):205-11. PubMed ID: 16704474
[TBL] [Abstract][Full Text] [Related]
34. First-trimester Down syndrome screening performance in the Dutch population; how to achieve further improvement?
Wortelboer EJ; Koster MP; Stoutenbeek P; Elvers LH; Loeber JG; Visser GH; Schielen PC
Prenat Diagn; 2009 Jun; 29(6):588-92. PubMed ID: 19294632
[TBL] [Abstract][Full Text] [Related]
35. Screening for triploidy by the risk algorithms for trisomies 21, 18 and 13 at 11 weeks to 13 weeks and 6 days of gestation.
Kagan KO; Anderson JM; Anwandter G; Neksasova K; Nicolaides KH
Prenat Diagn; 2008 Dec; 28(13):1209-13. PubMed ID: 19039823
[TBL] [Abstract][Full Text] [Related]
36. Comparison of first and second trimester aneuploidy risk assessment.
Reddy UM; Wapner RJ
Clin Obstet Gynecol; 2007 Jun; 50(2):442-53. PubMed ID: 17513930
[TBL] [Abstract][Full Text] [Related]
37. Pregnancies conceived using assisted reproductive technologies (ART) have low levels of pregnancy-associated plasma protein-A (PAPP-A) leading to a high rate of false-positive results in first trimester screening for Down syndrome.
Amor DJ; Xu JX; Halliday JL; Francis I; Healy DL; Breheny S; Baker HW; Jaques AM
Hum Reprod; 2009 Jun; 24(6):1330-8. PubMed ID: 19246467
[TBL] [Abstract][Full Text] [Related]
38. Second trimester prenatal screening for Down syndrome: the associations between the levels of serum markers in successive pregnancies.
Huang T; Boucher K; Summers AM
Prenat Diagn; 2007 Dec; 27(12):1138-42. PubMed ID: 17960787
[TBL] [Abstract][Full Text] [Related]
39. [Evaluation of plasmatic A protein as only marker during first trimester of pregnancy].
Salazar López R; Ibarra Gallardo AL; Iduma Meléndrez M; Leyva R
Ginecol Obstet Mex; 2008 Oct; 76(10):576-81. PubMed ID: 19062506
[TBL] [Abstract][Full Text] [Related]
40. Fifteen years of triple tests in The Netherlands; the life cycle of a screening test.
Wortelboer EJ; Koster MP; Stoutenbeek P; Loeber JG; Visser GH; Schielen PC
Prenat Diagn; 2008 Oct; 28(10):950-5. PubMed ID: 18821712
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
